|
|
Michael Rubart, Douglas P. Zipes
J Clin Invest. 2005;
115(9):2305
doi:10.1172/JCI26381
Abstract |
Full text
| PDF
D
espite recent advances in preventing sudden cardiac death (SCD) due to cardiac arrhythmia, its incidence in the population at large has remained unacceptably high. Better understanding of the interaction among various functional, structural, and genetic factors underlying the susceptibility to, and initiation of, fatal arrhythmias is a major goal and will provide new tools for the prediction, prevention, and therapy of SCD. Here, we review the role of aberrant intracellular Ca2+ handling, ionic imbalances associated with acute myocardial ischemia, neurohumoral changes, and genetic predisposition in the pathogenesis of SCD due to cardiac arrhythmia. Therapeutic measures to prevent SCD are also discussed.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(80)
| Title and authors |
Publication |
Year |
Dynamic monitoring of beating periodicity of stem cell-derived cardiomyocytes as a predictive tool for preclinical safety assessment : Microelectronic monitoring of functional cardiotoxicity
Yama A Abassi, Biao Xi, Nan Li, Wei Ouyang, Alexander Seiler, Manfred Watzele, Ralf Kettenhofen, Heribert Bohlen, Andreas Ehlich, Eugen Kolossov
|
British Journal of Pharmacology
|
2012 |
Neural Remodeling and Ventricular Arrhythmias: Understanding the Mechanism
Elad Anter
|
Cardiology
|
2012 |
Ontogeny of Cardiac Sympathetic Innervation and Its Implications for Cardiac Disease
Joshua W. Vincentz, Michael Rubart, Anthony B. Firulli
|
Pediatr Cardiol
|
2012 |
New drugs vs. old concepts: A fresh look at antiarrhythmics
Jérôme Thireau, Jean-Luc Pasquié, Eric Martel, Jean-Yves Le Guennec, Sylvain Richard
|
Pharmacology & Therapeutics
|
2011 |
Effects of cilostazol in the heart
Natnicha Kanlop, Siriporn Chattipakorn, Nipon Chattipakorn
|
Journal of Cardiovascular Medicine
|
2011 |
Myocardial fibrosis as a risk stratifier for sudden arrhythmic death
Ali A Sovari, Hrayr S Karagueuzian
|
Expert Rev Cardiovasc Ther
|
2011 |
Preservation of TSPO by chronic intermittent hypobaric hypoxia confers antiarrhythmic activity
Jun Li, Jiahong Xu, Junjie Xiao, Hong Zhang, Dandan Liang, Yi Liu, Yangyang Zhang, Ying Liu, Wei Wen, Yaer Hu, Zhuo Yu, Biao Yan, Bing Jiang, Zhao-Nian Zhou, Yi-Han Chen
|
Journal of Cellular and Molecular Medicine
|
2011 |
Short-term memory and electrical restitution in the canine transmural ventricle
Hong Zhang, Takeshi Ueyama, Juan Wang, Rui-Juan Wu, Shien-Fong Lin
|
Physiol. Meas.
|
2011 |
Ventricular Tachyarrhythmias in Patients Receiving an Implantable Cardioverter-Defibrillator for Primary versus Secondary Prophylaxis Indications
AMIN MANUCHEHRY, KARTIK AGUSALA, MAURO MONTEVECCHI, ALAN KADISH, ROD PASSMAN
|
Pacing and Clinical Electrophysiology
|
2011 |
Arrhythmia triggers in heart failure: The smoking gun of [Ca2+]i dysregulation
Gary L. Aistrup, C. William Balke, J. Andrew Wasserstrom
|
Heart Rhythm
|
2011 |
|